Yasushi Ohkusa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yasushi Ohkusa has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Tamie Sugawara
Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
21 shared publicationsKiyosu Taniguchi
National Hospital Organization Mie National Hospital, Mie, Japan
14 shared publicationsNobuhiko Okabe
Kawasaki City Institute for Public Health, Kanagawa, Japan
13 shared publicationsChiaki Miyazaki
Fukuoka City Social Welfare Foundation, Fukuoka, Japan
8 shared publications- Junko Kurita
Department of Nursing, Faculty of Sports & Health Science, Daito Bunka University, Saitama, Japan; Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences, Ibaraki, Japan
6 shared publications - Tamie Sugawara
National Institute of Infectious Diseases, Tokyo, Japan
5 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 166, 108553
Association of severe abnormal behavior of influenza patients and administered anti-influenza virus drugs: 2006-2022
- 18 March 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 166, 108553
Open AccessAssociation of severe abnormal behavior of influenza patients and administered anti-influenza virus drugs: 2006-2022
- 1 October 2021
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 15 (5) , 261-267
Association of bleeding symptoms during influenza infection and administered drugs
On March 1, 2019, the Ministry of Health, Labour and Welfare added bleeding symptoms to adverse reaction package inserts as a possible adverse event for a new anti-influenza drug, baloxavir marboxil, because 13 patients with bleeding symptoms were identified among influenza patients taking the drug. Nevertheless, aspects of the epidemiology of bleeding symptoms among influenza patients remain unclear. This study elucidated bleeding symptoms among influenza patients and hospitalized patients as severe cases. A survey was administered to all physicians in Japan during the 2019-2020 season for reporting of bleeding symptoms in influenza patients. The survey elicited information about outcomes, assuming associated underlying diseases and drugs in addition to administered drugs including acetaminophen and anti-influenza (antiviral) drugs. We received reports of 63 cases with bleeding symptoms, including 5 cases of hospitalized patients. Among all patients, 54% had been administered oseltamivir; 10% had been administered baloxavir marboxil. Among hospitalized patients, all had been administered acetaminophen; 40% of them had been administered oseltamivir, and one patient had been administered baloxavir marboxil. Accumulation of bleeding symptom cases is expected to be necessary to evaluate the association.
- 1 October 2021
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 15 (5) , 261-267
Association of bleeding symptoms during influenza infection and administered drugs
On March 1, 2019, the Ministry of Health, Labour and Welfare added bleeding symptoms to adverse reaction package inserts as a possible adverse event for a new anti-influenza drug, baloxavir marboxil, because 13 patients with bleeding symptoms were identified among influenza patients taking the drug. Nevertheless, aspects of the epidemiology of bleeding symptoms among influenza patients remain unclear. This study elucidated bleeding symptoms among influenza patients and hospitalized patients as severe cases. A survey was administered to all physicians in Japan during the 2019-2020 season for reporting of bleeding symptoms in influenza patients. The survey elicited information about outcomes, assuming associated underlying diseases and drugs in addition to administered drugs including acetaminophen and anti-influenza (antiviral) drugs. We received reports of 63 cases with bleeding symptoms, including 5 cases of hospitalized patients. Among all patients, 54% had been administered oseltamivir; 10% had been administered baloxavir marboxil. Among hospitalized patients, all had been administered acetaminophen; 40% of them had been administered oseltamivir, and one patient had been administered baloxavir marboxil. Accumulation of bleeding symptom cases is expected to be necessary to evaluate the association.
- Open Access
- 15 February 2021
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 7 (2) , e20335
Evaluating Apple Inc Mobility Trend Data Related to the COVID-19 Outbreak in Japan: Statistical Analysis
Background: In Japan, as a countermeasure against the COVID-19 outbreak, both the national and local governments issued voluntary restrictions against going out from residences at the end of March 2020 in preference to the lockdowns instituted in European and North American countries. The effect of such measures can be studied with mobility data, such as data which is generated by counting the number of requests made to Apple Maps for directions in select countries/regions, sub-regions, and cities. Objective: We investigate the associations of mobility data provided by Apple Inc and an estimate an an effective reproduction number R(t). Methods: We regressed R(t) on a polynomial function of daily Apple data, estimated using the whole period, and analyzed subperiods delimited by March 10, 2020. Results: In the estimation results, R(t) was 1.72 when voluntary restrictions against going out ceased and mobility reverted to a normal level. However, the critical level of reducing R(t) to <1 was obtained at 89.3% of normal mobility. Conclusions: We demonstrated that Apple mobility data are useful for short-term prediction of R(t). The results indicate that the number of trips should decrease by 10% until herd immunity is achieved and that higher voluntary restrictions against going out might not be necessary for avoiding a re-emergence of the outbreak.
- 15 February 2021
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 7 (2) , e20335
Open AccessEvaluating Apple Inc Mobility Trend Data Related to the COVID-19 Outbreak in Japan: Statistical Analysis
Background: In Japan, as a countermeasure against the COVID-19 outbreak, both the national and local governments issued voluntary restrictions against going out from residences at the end of March 2020 in preference to the lockdowns instituted in European and North American countries. The effect of such measures can be studied with mobility data, such as data which is generated by counting the number of requests made to Apple Maps for directions in select countries/regions, sub-regions, and cities. Objective: We investigate the associations of mobility data provided by Apple Inc and an estimate an an effective reproduction number R(t). Methods: We regressed R(t) on a polynomial function of daily Apple data, estimated using the whole period, and analyzed subperiods delimited by March 10, 2020. Results: In the estimation results, R(t) was 1.72 when voluntary restrictions against going out ceased and mobility reverted to a normal level. However, the critical level of reducing R(t) to <1 was obtained at 89.3% of normal mobility. Conclusions: We demonstrated that Apple mobility data are useful for short-term prediction of R(t). The results indicate that the number of trips should decrease by 10% until herd immunity is achieved and that higher voluntary restrictions against going out might not be necessary for avoiding a re-emergence of the outbreak.
- 1 January 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (1) , 62-64
Estimated effectiveness of school closure and voluntary event cancellation as COVID-19 countermeasures in Japan
- 1 January 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (1) , 62-64
Estimated effectiveness of school closure and voluntary event cancellation as COVID-19 countermeasures in Japan
- Open Access
Interim evaluation of Google AI forecasting for COVID-19 compared with statistical forecasting by human intelligence in the first week
Background: Since June, Google (Alphabet Inc.) has provided forecasting for COVID-19 outbreak by artificial intelligence (AI) in the USA. In Japan, they provided similar services from November, 2020. Object: We compared Google AI forecasting with a statistical model by human intelligence. Method: We regressed the number of patients whose onset date was day t on the number of patients whose past onset date was 14 days prior, with information about traditional surveillance data for common pediatric infectious diseases including influenza, and prescription surveillance 7 days prior. We predicted the number of onset patients for 7 days, prospectively. Finally, we compared the result with Googles AI-produced forecast. We used the discrepancy rate to evaluate the precision of prediction: the sum of absolute differences between data and prediction divided by the aggregate of data. Results: We found Google prediction significantly negative correlated with the actual observed data, but our model slightly correlated but not significant. Moreover, discrepancy rate of Google prediction was 27.7% for the first week. The discrepancy rate of our model was only 3.47%. Discussion and Conclusion: Results show Googles prediction has negatively correlated and greater difference with the data than our results. Nevertheless, it is noteworthy that this result is tentative: the epidemic curve showing newly onset patients was not fixed.
Open AccessInterim evaluation of Google AI forecasting for COVID-19 compared with statistical forecasting by human intelligence in the first week
Background: Since June, Google (Alphabet Inc.) has provided forecasting for COVID-19 outbreak by artificial intelligence (AI) in the USA. In Japan, they provided similar services from November, 2020. Object: We compared Google AI forecasting with a statistical model by human intelligence. Method: We regressed the number of patients whose onset date was day t on the number of patients whose past onset date was 14 days prior, with information about traditional surveillance data for common pediatric infectious diseases including influenza, and prescription surveillance 7 days prior. We predicted the number of onset patients for 7 days, prospectively. Finally, we compared the result with Googles AI-produced forecast. We used the discrepancy rate to evaluate the precision of prediction: the sum of absolute differences between data and prediction divided by the aggregate of data. Results: We found Google prediction significantly negative correlated with the actual observed data, but our model slightly correlated but not significant. Moreover, discrepancy rate of Google prediction was 27.7% for the first week. The discrepancy rate of our model was only 3.47%. Discussion and Conclusion: Results show Googles prediction has negatively correlated and greater difference with the data than our results. Nevertheless, it is noteworthy that this result is tentative: the epidemic curve showing newly onset patients was not fixed.
- Open Access
Effectiveness of COCOA, a COVID-19 contact notification application, in Japan
Background: COCOA, a contact reporting application in Japan, was launched at the end of June 2020. Object: We assessed effectiveness of COCOA. Method: After developing a simple susceptible–infected–recovery model with COCOA and voluntary restrictions against going out (VRG), we assumed that COCOA can reduce infectiousness by 10–50% points through self-quarantine at home after receiving notification from COCOA. Results: COCOA alone is insufficient to halt an outbreak. Even if the entire population were to use COCOA, the reproduction number would be 1.31. However, if VRG were 15%, about half of the maximum VRG effectiveness under the emergency state declaration, then 10% COCOA use by a population can reduce the reproduction number to less than one. Conclusion: Significant effects of COCOA for reducing the reproduction number were found. However, without VRG, COCOA alone is insufficient to control an outbreak.
Open AccessEffectiveness of COCOA, a COVID-19 contact notification application, in Japan
Background: COCOA, a contact reporting application in Japan, was launched at the end of June 2020. Object: We assessed effectiveness of COCOA. Method: After developing a simple susceptible–infected–recovery model with COCOA and voluntary restrictions against going out (VRG), we assumed that COCOA can reduce infectiousness by 10–50% points through self-quarantine at home after receiving notification from COCOA. Results: COCOA alone is insufficient to halt an outbreak. Even if the entire population were to use COCOA, the reproduction number would be 1.31. However, if VRG were 15%, about half of the maximum VRG effectiveness under the emergency state declaration, then 10% COCOA use by a population can reduce the reproduction number to less than one. Conclusion: Significant effects of COCOA for reducing the reproduction number were found. However, without VRG, COCOA alone is insufficient to control an outbreak.
- Open Access
Huge Excess Mortality due to the delta strain of COVID-19 in Japan in August and September, 2021
Background: No remarkable mortality attributable to COVID-19 confirmed by PCR test has been observed in Japan. Object: We sought to quantify excess mortality using the National Institute of Infectious Diseases (NIID) model. Method: We applied the NIID model to deaths of all causes from 1987 up through October, 2021 for the whole of Japan and up through August, 2021 for Tokyo. Results: Results in Japan show huge number of excess mortality, up to 10 thousands in the two months, in August and September, 2021. On the other hand, in Tokyo, 1323 excess mortality was detected Discussion and Conclusion: We detected substantial excess mortality in Japan in August and September, 2021 and in Tokyo in August, 2021. It might be important to continue to monitor excess mortality of COVID-19 carefully hereafter.
Open AccessHuge Excess Mortality due to the delta strain of COVID-19 in Japan in August and September, 2021
Background: No remarkable mortality attributable to COVID-19 confirmed by PCR test has been observed in Japan. Object: We sought to quantify excess mortality using the National Institute of Infectious Diseases (NIID) model. Method: We applied the NIID model to deaths of all causes from 1987 up through October, 2021 for the whole of Japan and up through August, 2021 for Tokyo. Results: Results in Japan show huge number of excess mortality, up to 10 thousands in the two months, in August and September, 2021. On the other hand, in Tokyo, 1323 excess mortality was detected Discussion and Conclusion: We detected substantial excess mortality in Japan in August and September, 2021 and in Tokyo in August, 2021. It might be important to continue to monitor excess mortality of COVID-19 carefully hereafter.
- Open Access
- 16 May 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating Apple Inc Mobility Trend Data Related to the COVID-19 Outbreak in Japan: Statistical Analysis (Preprint)
BACKGROUND In Japan, as a countermeasure against the COVID-19 outbreak, both the national and local governments issued voluntary restrictions against going out from residences at the end of March 2020 in preference to the lockdowns instituted in European and North American countries. The effect of such measures can be studied with mobility data, such as data which is generated by counting the number of requests made to Apple Maps for directions in select countries/regions, sub-regions, and cities. OBJECTIVE We investigate the associations of mobility data provided by Apple Inc and an estimate an an effective reproduction number R(t). METHODS We regressed R(t) on a polynomial function of daily Apple data, estimated using the whole period, and analyzed subperiods delimited by March 10, 2020. RESULTS In the estimation results, R(t) was 1.72 when voluntary restrictions against going out ceased and mobility reverted to a normal level. However, the critical level of reducing R(t) to <1 was obtained at 89.3% of normal mobility. CONCLUSIONS We demonstrated that Apple mobility data are useful for short-term prediction of R(t). The results indicate that the number of trips should decrease by 10% until herd immunity is achieved and that higher voluntary restrictions against going out might not be necessary for avoiding a re-emergence of the outbreak.
- 16 May 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating Apple Inc Mobility Trend Data Related to the COVID-19 Outbreak in Japan: Statistical Analysis (Preprint)
BACKGROUND In Japan, as a countermeasure against the COVID-19 outbreak, both the national and local governments issued voluntary restrictions against going out from residences at the end of March 2020 in preference to the lockdowns instituted in European and North American countries. The effect of such measures can be studied with mobility data, such as data which is generated by counting the number of requests made to Apple Maps for directions in select countries/regions, sub-regions, and cities. OBJECTIVE We investigate the associations of mobility data provided by Apple Inc and an estimate an an effective reproduction number R(t). METHODS We regressed R(t) on a polynomial function of daily Apple data, estimated using the whole period, and analyzed subperiods delimited by March 10, 2020. RESULTS In the estimation results, R(t) was 1.72 when voluntary restrictions against going out ceased and mobility reverted to a normal level. However, the critical level of reducing R(t) to <1 was obtained at 89.3% of normal mobility. CONCLUSIONS We demonstrated that Apple mobility data are useful for short-term prediction of R(t). The results indicate that the number of trips should decrease by 10% until herd immunity is achieved and that higher voluntary restrictions against going out might not be necessary for avoiding a re-emergence of the outbreak.
- Open Access
Forecast of the COVID-19 outbreak and effects of self-restraint in going out in Tokyo, Japan
Background: The number of patients of COVID-19 in Tokyo has been increasing gradually through the end of March, 2020. Object: Support for policymaking requires forecasting of the entire course and outcome of the outbreak if a self-restraint in going out is not initiated. Moreover, the effects of a self-restraint in going out must be considered when choosing to initiate one. Method: Data of Tokyo patients with symptoms during January 14 – March 28, 2020 were used to formulate a susceptible–infected–recovered (SIR) model using three age classes and to estimate the basic reproduction number (R 0 ). Based on the estimated R 0 , We inferred outbreak outcomes and medical burden if a self-restraint in going out were not enacted. Then we estimate the self-restraint in going out effects. Results: Results suggest R 0 as 2.86, with a 95% confidence interval of [2.73, 2.97]. Exhaustion of medical resources can be expected to occur on April 26 if no self-restraint in going out occurs. If a self-restraint in going out were enacted from April 6, and if more than 60% of trips outside the home were restricted voluntarily, then medical care service could be maintained. Discussion and Conclusion: The estimated R 0 was similar to that found from other studies conducted in China and Japan. Results demonstrate that a self-restraint in going out with reasonable cooperation of residents is required to maintain medical care.
Open AccessForecast of the COVID-19 outbreak and effects of self-restraint in going out in Tokyo, Japan
Background: The number of patients of COVID-19 in Tokyo has been increasing gradually through the end of March, 2020. Object: Support for policymaking requires forecasting of the entire course and outcome of the outbreak if a self-restraint in going out is not initiated. Moreover, the effects of a self-restraint in going out must be considered when choosing to initiate one. Method: Data of Tokyo patients with symptoms during January 14 – March 28, 2020 were used to formulate a susceptible–infected–recovered (SIR) model using three age classes and to estimate the basic reproduction number (R 0 ). Based on the estimated R 0 , We inferred outbreak outcomes and medical burden if a self-restraint in going out were not enacted. Then we estimate the self-restraint in going out effects. Results: Results suggest R 0 as 2.86, with a 95% confidence interval of [2.73, 2.97]. Exhaustion of medical resources can be expected to occur on April 26 if no self-restraint in going out occurs. If a self-restraint in going out were enacted from April 6, and if more than 60% of trips outside the home were restricted voluntarily, then medical care service could be maintained. Discussion and Conclusion: The estimated R 0 was similar to that found from other studies conducted in China and Japan. Results demonstrate that a self-restraint in going out with reasonable cooperation of residents is required to maintain medical care.
- Open Access
- 29 February 2020
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 14 (1) , 50-53
Association of moderately abnormal behavior and administered neuraminidase inhibitors
Our earlier study investigated the incidence of severe abnormal behavior associated with neuraminidase inhibitors (NIs), but some studies have specifically examined the association of oseltamivir use and moderately abnormal behavior. Therefore, this study was undertaken to assess associations between moderately abnormal behavior and administered drugs. All cases of patients with influenza who exhibited moderately abnormal behavior were reported to us by physicians of all sentinel clinics and hospitals for influenza throughout Japan. Open Data of the National Database of Electronic Medical Claims include the numbers of patients diagnosed as having influenza who were prescribed NI. Incidence by NI was tested using Fisher's exact test. We received 518 moderately abnormal cases in 5-9-year-olds and 207 moderately abnormal behavior cases in 10-19-year-olds. The incidence among NI ranged from 193 per one million influenza patients in laninamivir among 10-19-year-olds to 1021 for peramivir among 5-9-year-olds. Estimation results revealed the order of risk among NIs as peramivir, oseltamivir, zanamivir and laninamivir in moderate abnormal behavior. Because of data limitations, risk among patients with and without NI cannot be compared.
- 29 February 2020
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 14 (1) , 50-53
Open AccessAssociation of moderately abnormal behavior and administered neuraminidase inhibitors
Our earlier study investigated the incidence of severe abnormal behavior associated with neuraminidase inhibitors (NIs), but some studies have specifically examined the association of oseltamivir use and moderately abnormal behavior. Therefore, this study was undertaken to assess associations between moderately abnormal behavior and administered drugs. All cases of patients with influenza who exhibited moderately abnormal behavior were reported to us by physicians of all sentinel clinics and hospitals for influenza throughout Japan. Open Data of the National Database of Electronic Medical Claims include the numbers of patients diagnosed as having influenza who were prescribed NI. Incidence by NI was tested using Fisher's exact test. We received 518 moderately abnormal cases in 5-9-year-olds and 207 moderately abnormal behavior cases in 10-19-year-olds. The incidence among NI ranged from 193 per one million influenza patients in laninamivir among 10-19-year-olds to 1021 for peramivir among 5-9-year-olds. Estimation results revealed the order of risk among NIs as peramivir, oseltamivir, zanamivir and laninamivir in moderate abnormal behavior. Because of data limitations, risk among patients with and without NI cannot be compared.